Society of Cardiovascular Computed Tomography Cardiovascular Disease Prevention Symposium 2022
Format: 1 video + 1 pdf, size: 10.3 GB
Course Audience: radiology physician, cardiology physician
August 13 (Video MP4 Format)
Program (PDF Format)
* Detail:
Program
Time | Session | Speaker |
10:00am – 10:20am | Cleerly Inc. Sponsored Symposium | Staging Atherosclerosis andPersonalizing Prevention: A Standardized Paradigm of Treatment | Andrew Freeman, MD |
10:30am – 10:35am | Introduction and overview | Ron Blankstein, MD, MSCCT |
Session 1: The big picture in prevention | ||
10:35am – 11:35am | Session Moderators | Ron Blankstein, MD, MSCCT & Khurram Nasir, MD, MPH, FSCCT |
10:35am – 10:45am | CAC beyond statins – The future is now | Michael Blaha, MD |
10:45am – 10:55am | The expanding role for CCTA in CVD prevention | Ron Blankstein, MD, MSCCT |
10:55am – 11:05am | Incorporating social determinants of health in CVD prevention | Khurram Nasir, MD, FSCCT |
11:05am – 11:15am | Novel interventions to address disparities in CVD prevention | Fatima Rodriguez, MD |
11:15am – 11:35am | Q & A | Live Panel Discussion |
11:35am – 11:40am | Wrap up | |
Session 2: How do I reduce risk in ….. | ||
11:40am – 12:40pm | Session Moderator | Martha Gulati, MD, MS |
11:40am – 11:50am | Familial hypercholesterolemia | Raul Santos, MD, PhD, MSc |
11:50am – 12:00pm | Statin intolerance | Carl Orringer, MD |
12:00pm – 12:10pm | Systemic inflammatory diseases | Nehal Mehta, MD |
12:10pm – 12:20pm | Severely elevated CAC | Roger Blumenthal, MD, FSCCT |
12:20pm – 12:40pm | Q & A | Live Panel Discussion |
12:40pm – 12:45pm | Wrap up | |
12:45pm – 1:30pm | Lunch break & keynote address | |
12:45pm – 1:00pm | Keynote talk: The Future of Cardiovascular Disease Prevention | Eugene Braunwald, MD |
Session 3: New therapeutics | ||
1:30pm – 2:30pm | Session Moderator | Matthew Budoff, MD, MSCCT |
1:30pm – 1:40pm | Lowering Lipoprotein(a) | Sam Tsimikis, MD |
1:40pm – 1:50pm | Lowering Triglycerides | Michael Shapiro, MD, FSCCT |
1:50pm – 2:00pm | Reducing CV risk in diabetes | Pam Taub, MD |
2:00pm – 2:10pm | New therapeutic options for weight loss | Robert Kushner, MD |
2:10pm – 2:30pm | Q & A | Live Panel Discussion |
2:30pm – 2:35pm | Wrap up | |
Session 4: Lifestyle interventions | ||
2:35pm – 3:25pm | Session Moderator | Roger Blumenthal, MD, FSCCT |
2:35pm – 2:45pm | How to advise patients on adopting a plant based diet | Danielle Belardo, MD |
2:45pm – 2:55pm | Sex based differences in hypertension | Martha Gulati, MD, MS |
2:55pm – 3:05pm | Practical recommendations for improving adherence in ASCVD Risk | Erin Michos, MD, MHS |
3:05pm – 3:25pm | Q & A | Live Panel Discussion |
3:25pm – 3:30pm | Closing remarks | Ron Blankstein, MD, MSCCT |
3:35pm – 3:55pm | Regeneron Sponsored Symposium | Learn how EVKEEZA inhibits ANGPTL3 |